Proton beam therapy for a patient with a giant thymic carcinoid tumor and severe superior vena cava syndrome

Rare Tumors. 2014 May 13;6(2):5177. doi: 10.4081/rt.2014.5177.

Abstract

Surgical resection is the first choice for treatment of a thymic carcinoid tumor and radiotherapy is often performed as adjuvant therapy. Here, we report a case of an unresectable and chemoresistant thymic carcinoid tumor that was treated successfully using standalone proton beam therapy (PBT). The patient was a 66-year-old woman in whom surgical resection of the tumor was impossible because of cardiac invasion. Therefore, chemotherapy was administered. However, the tumor grew to 15 cm in diameter and she developed severe superior vena cava (SVC) syndrome. She was referred to our hospital and received PBT at a dose of 74 GyE in 37 fractions. PBT was conducted without severe early toxicities. After PBT, the tumor mildly shrunk to 13 cm in diameter and SVC syndrome almost disappeared. Subsequently, the tumor has continued to decrease in size slowly over the last 2 years and late toxicities have not been observed. Our experience with this case suggests that PBT may be effective for an unresectable thymic carcinoid tumor.

Keywords: mediastinal tumor; proton beam therapy; radiation; superior vena cava syndrome; thymic carcinoid tumor.

Publication types

  • Case Reports

Grants and funding

Funding: This work was supported in part by Grants-in-Aid for Scientific Research (B) (24390286), Challenging Exploratory Research (24659556), and Young Scientists (B) (25861064) from the Ministry of Education, Science, Sports and Culture of Japan.